Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic Studies of Gilles de la Tourette Syndrome

ABSTRACT: Genomic Studies of Gilles de la Tourette Syndrome

PROVIDER: PRJNA390461 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Homo sapiens

Project description:Genomic Studies of Gilles de la Tourette Syndrome

| PRJNA390462 | ENA

Gene expression correlated with inattention and hyperactivity/impulsivity rating scales in Tourette syndrome

Project description:Inattention, impulsivity and hyperactivity are the primary behaviors associated with Attention Deficit / Hyperactivity Disorder (ADHD). Previous studies proved that peripheral blood gene expression signature could mirror central nervous system disease. This study determined if gene expression in blood correlated with inattention, hyperactivity/impulsivity rating scales and/or both in subjects with Tourette syndrome (TS).

2014-06-30 | GSE30470 | GEO

Collaborative Genomic Studies of Tourette Disorder II

Project description:Collaborative Genomic Studies of Tourette Disorder II

| PRJNA694740 | ENA

Studies of Tourette disorder and related conditions

Project description:Studies of Tourette disorder and related conditions

| PRJNA397301 | ENA

évaluation de l’efficacité et de la tolérance de deux stratégies de traitements de chimiothérapie (escalade de doses versus désescalade de doses) chez des patients ayant un cancer colorectal métastatique

Project description:Primary objectives: L’objectif principal est d’évaluer le taux de patients sans échec de la stratégie expérimentale 16 mois après la randomisation. Primary endpoints: Le taux de patients sans échec de la stratégie après la randomisation. L’échec de la stratégie est défini par: • Progression (définie dans chaque bras)* en utilisant les critères RECIST v1.1 ou• Décès (toutes causes confondues) ou• Toxicité conduisant à l’arrêt définitif d’un des produits de la chimiothérapie (oxaliplatine et/ou irinotécan) • Refus du patient de poursuivre la stratégie • Décision de l’investigateur d’arrêter la stratégie

| 2746728 | ecrin-mdr-crc

Blocking Phenomena in Gilles de la Tourette Syndrome.

Project description: Not available

| S-EPMC6353507 | biostudies-literature

Blocking Tics in Gilles de la Tourette Syndrome.

Project description: Not available

| S-EPMC8201401 | biostudies-literature

Peripheral blood transcriptomics identifies cohesin–chromatin and immune dysregulation in tics and Tourette syndrome

Project description:Tic disorders and Tourette syndrome are neurodevelopmental disorders arising from interplay between genetic and environmental factors. Gene regulation, via chromatin and other epigenetic mechanisms, may provide a key link between gene-environment interactions, yet remains under-investigated in tic disorders. We performed bulk RNA sequencing of peripheral blood from 28 children with tic disorders (19 with Tourette syndrome, aged 6-16, median age 10 years, 18 (64%) males) compared to 20 matched healthy controls (aged 1-25, median age 11 years, 13 (65%) males). Differentially expressed genes (DEGs) were identified following false discovery rate (FDR) correction, and pathway enrichment was analysed using Gene Set Enrichment Analysis (GSEA) based on Gene Ontology (GO) and Reactome databases. To assess convergence between peripheral and brain molecular changes, DEGs were compared with published post-mortem brain transcriptomic data from individuals with Tourette syndrome. A total of 4,169 DEGs (FDR < 0.05) were identified in blood transcriptomic analysis, with 2,192 upregulated and 1,977 downregulated genes. The blood transcriptomic findings included upregulation of chromatin- and cohesin-related pathways, immune activation, and cell signalling, and downregulation of translational machinery, mitochondrial function, and DNA methylation. Comparison with post-mortem brain transcriptomic data revealed 30 overlapping genes, including 20 that were concordantly upregulated in both blood and brain, predominantly associated with immune, signalling, and cellular stress responses. Our data points to gene regulation and chromatin biology as a nexus where genetic risk and environmental exposures converge in tic disorders and related neurodevelopmental disorders, and highlight epigenetic and immune-targeting therapies as promising avenues for disease modification.

2026-05-14 | GSE310998 | GEO

Étude de la toxicité cutanée du cétuximab (anti-Epidermal Growth Factor Receptor): recherche d’un lien entre la réponse inflammatoire cutanée et la réponse radiologique.

Project description:Primary objectives: Analyser le profil de la réponse inflammatoire cutanée des patients traités par anti-EGFR et de rechercher le lien avec la réponse radiologique Primary endpoints: Le critère de jugement principal est la variation du taux des différents marqueurs inflammatoires cutanés présents au niveau des biopsies cutanées pré et post-thérapeutiques en fonction de la réponse radiologique.

| 2528067 | ecrin-mdr-crc

Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome.

Project description: Not available

| S-EPMC7297729 | biostudies-literature